IMMUTEP LIMITED — Director's Dealing 2023

Nov 22, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	IMMUTEP LIMITED (ASX: IMM)
ABN	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Russell John Howard
Date of last notice	2 May 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Regulus Star Pty Ltd <Regulus Star P/L A/C>(Russell Howard)
Date of change	23 November 2023
No. of securities held prior to change	1. 1,113,207 Fully Paid Ordinary Shares2. 226,414 Director Performance Rights
Class	N/A
Number acquired	178,356 Director Performance Rights (ASX:IMMAM)
Number disposed	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluationNo. of securities held after changeNature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back

NilThe additional Performance Rights wereissued to Dr Howard as an increase in hisremuneration for his services as a Director ofthe Company in lieu of cash for directors’fees in accordance with shareholder approvalobtained at the 2023 Annual General Meeting(AGM) held on 24 October 2023.The number of performance rights is basedon approximately 3.57 years of directors’fees at $16,500 per annum divided by $0.33(being the 5-day VWAP up to and including20 July 2023).28,356 of the Performance Rights are vested.The balance will vest in 3 equal tranches on1 December 2024, 1 December 2025 and 1December 20261. 1,113,207 Fully Paid Ordinary Shares2. 404,770 Director Performance Rights178,356 Director Performance Rights tosubscribe for 178,356 Shares were issued toDr Howard in accordance with shareholderapproval obtained at the 2023 AGM.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contractNature of interestName of registered holder(if issued securities)	N/AN/AN/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	N/A
Interest after change	N.A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required?	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3